Arq. Bras. Cardiol. 2023; 120(4): e20230203

Brazilian Position Statement for Familial Chylomicronemia Syndrome – 2023

Maria Cristina de Oliveira Izar ORCID logo , Raul Dias dos Santos Filho ORCID logo , Marcelo Heitor Vieira Assad, Antonio Carlos Palandri Chagas ORCID logo , Alceu de Oliveira Toledo Júnior ORCID logo , Ana Cláudia Cavalcante Nogueira ORCID logo , Ana Cristina Carneiro Fernandes Souto ORCID logo , Ana Maria Lottenberg ORCID logo , Ana Paula Marte Chacra ORCID logo , Carlos Eduardo dos Santos Ferreira ORCID logo , Charles Marques Lourenço ORCID logo , Cynthia Melissa Valerio ORCID logo , Dennys Esper Cintra ORCID logo , Francisco Antonio Helfenstein Fonseca ORCID logo , Gustavo Aguiar Campana, Henrique Tria Bianco ORCID logo , Josivan Gomes de Lima ORCID logo , Maria Helane Costa Gurgel Castelo ORCID logo , Marileia Scartezini ORCID logo , Miguel Antonio Moretti ORCID logo , Natasha Slhessarenko Fraife Barreto ORCID logo , Rayana Elias Maia ORCID logo , Renan Magalhães Montenegro Junior ORCID logo , Renato Jorge Alves ORCID logo , Roberta Marcondes Machado Figueiredo ORCID logo , Rodrigo Ambrosio Fock ORCID logo , Tânia Leme da Rocha Martinez ORCID logo , Viviane Zorzanelli Rocha Giraldez

DOI: 10.36660/abc.20230203

1. Cover Letter

Familial chylomicronemia syndrome (FCS) is a severe form of dyslipidemia characterized by multiple signs and symptoms associated with a deficiency in lipoprotein lipase or one of its cofactors, leading to compromised triglyceride metabolism. FCS has an autosomal recessive pattern of inheritance and affects approximately 1 to 2 people per million, but it may be more frequent in consanguineous relationships. Knowledge of this condition is still limited, often contributing to delayed diagnosis when complications have already set in. Patients with FCS may have recurrent abdominal pain, episodes of pancreatitis, eruptive xanthomas, lipemia retinalis , hepatosplenomegaly, and a milky appearance of serum.

In classic, severe forms, clinical symptoms are present at birth or even in childhood, but they may manifest at any age, especially in carriers of new mutations. Patients with FCS usually see several specialists before a diagnosis is made. The clinical presentation of FCS may also be indistinguishable from that of multifactorial chylomicronemia syndrome, which is more common and also has a genetic basis, although it is influenced by environmental and lifestyle factors. In addition, multifactorial chylomicronemia syndrome may result from conditions such as hypothyroidism, uncontrolled diabetes, kidney disease, alcohol abuse, and use of certain medications, which makes its diagnosis even more difficult.

[…]

Brazilian Position Statement for Familial Chylomicronemia Syndrome – 2023

Comments

Skip to content